Eric Schmidt - May 24, 2021 Form 4 Insider Report for Allogene Therapeutics, Inc. (ALLO)

Role: Chief Financial Officer
Signature: /s/ Veer Bhavnagri, Attorney-in-Fact
Stock symbol: ALLO
Transactions as of: May 24, 2021
Transactions value $: $271,423
Form type: 4
Date filed: 5/26/2021, 08:00 AM
Next filing: Jun 24, 2021

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	ALLO	Common Stock	Options Exercise	$271K	+14.9K	+15.5%	$18.22^*	111K	May 24, 2021	Direct
holding	ALLO	Common Stock						1.15M	May 24, 2021	See footnote	F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	ALLO	Stock Option (Right to Buy)	Options Exercise	$0	-14.9K	-13.59%	$0.00	94.7K	May 24, 2021	Common Stock	14.9K	$18.22	Direct	F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The securities are held in the name of the Eric Schmidt 2017 Family Irrevocable Trust.
F2	25% of the shares subject to the stock option shall vest on the first anniversary of the grant date, and the remaining shares shall vest in 36 equal monthly installments thereafter.